Thank you for the answer.
Everybody talks about the difficulties that you as developers, as scientists, face when it comes to federal funding, when it comes to bureaucracy and when it comes to red tape. That has been the case for the last 10 years when it comes to making funds available for this vital research. Do you believe that enough of our federal dollars are being pushed to CIHR for AMR-related drugs in that context?